(Q39382652)

11 September 2017

title

Melatonin suppresses migration and invasion via inhibition of oxidative stress pathway in glioma cells (English)

1 reference

11 September 2017

0 references

5

Shidou Zhao

1 reference

11 September 2017

Juntao Wang

1

1 reference

11 September 2017

Hongbo Hao

2

1 reference

11 September 2017

Linli Yao

3

1 reference

11 September 2017

Xiaodan Zhang

4

1 reference

11 September 2017

Eng-Ang Ling

6

1 reference

11 September 2017

Aijun Hao

7

1 reference

11 September 2017

Gang Li

8

1 reference

11 September 2017

publication date

8 March 2012

1 reference

Journal of Pineal Research

11 September 2017

published in

1 reference

11 September 2017

volume

53

1 reference

11 September 2017

issue

2

1 reference

11 September 2017

page(s)

180-187

1 reference

The 2007 WHO classification of tumours of the central nervous system

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Treatment of malignant glioma: a problem beyond the margins of resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Pineal Melatonin: Cell Biology of Its Synthesis and of Its Physiological Interactions*

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Melatonin: the chemical expression of darkness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Rhythmic transcription: the molecular basis of circadian melatonin synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Human placental trophoblasts synthesize melatonin and express its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Melatonin, hormone of darkness and more: occurrence, control mechanisms, actions and bioactive metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Melatonin receptors: role on sleep and circadian rhythm regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Photoimmunomodulation and melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Antioxidants and neuroprotection in the adult and developing central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Melatonin and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Alzheimer's disease: pathological mechanisms and the beneficial role of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Melatonin and ischemia-reperfusion injury of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Interactions between melatonin and nicotinamide nucleotide: NADH preservation in cells and in cell-free systems by melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Regulation of antioxidant enzymes: a significant role for melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Basic mechanisms involved in the anti-cancer effects of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

ROCK-regulated cytoskeletal dynamics participate in the inhibitory effect of melatonin on cancer cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Melatonin increases stress fibers and focal adhesions in MDCK cells: participation of Rho-associated kinase and protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Melatonin induces neuritogenesis at early stages in N1E-115 cells through actin rearrangements via activation of protein kinase C and Rho-associated kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Intracellular signaling pathways involved in the cell growth inhibition of glioma cells by melatonin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

High glucose-induced expression of inflammatory cytokines and reactive oxygen species in cultured astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

ROS-NFkappaB mediates TGF-beta1-induced expression of urokinase-type plasminogen activator, matrix metalloproteinase-9 and cell invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

TGF-β1 increases invasiveness of SW1990 cells through Rac1/ROS/NF-κB/IL-6/MMP-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Cytoprotective effects of melatonin on C6 astroglial cells exposed to glutamate excitotoxicity and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Matrix metalloproteinases: regulators of the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Radical causes of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Cellular redox pathways as a therapeutic target in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Oxidative stress and apoptosis: impact on cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Activation of peroxisome proliferator-activated receptor gamma contributes to the survival of T lymphoma cells by affecting cellular metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Redox signaling in angiogenesis: role of NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

Redox regulation of cellular signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

NF-kappaB in cancer: a marked target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2012.00985.X

10.1111/J.1600-079X.2012.00985.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference